Physician
Frankel, Perry
Frankel, Perry was paid $948K by Medicaid between Jan 2018 and Apr 2022, across 40 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 40% of everything it billed.
33Billing provider infoFRANKEL, PERRY
MANHASSET, NY 11030
MANHASSET, NY 11030
33aNPI1912942921assigned 06/17/2006
33bProvider typeCardiovascular Disease Physician
28Total paid$948K
24GClaims26,933
24DCodes billed40
24AFirst – last monthJan 2018 – Apr 2022
Compared with peers
Next to other Cardiovascular Disease Physician providers in New York
Rank by total paid#62 of 1,564
Median peer was paid$13K
This provider vs. median73×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 788 | $82K | |
| 2020 | 2,389 | $76K | |
| 2021 | 19,264 | $606K | |
| 2022 | 4,492 | $184K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 40% | 11,865 | 6,434 | $376K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 13% | 3,919 | 2,044 | $127K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 11% | 2,453 | 2,378 | $104K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 8.6% | 1,366 | 1,229 | $82K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 8.4% | 1,113 | 1,001 | $80K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5.8% | 364 | 358 | $55K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.8% | 1,776 | 1,237 | $27K |
| 93880 | 2.0% | 159 | 157 | $19K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.6% | 178 | 173 | $15K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.3% | 328 | 327 | $12K |
| 86769 | 1.2% | 436 | 432 | $12K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 103 | 103 | $7K |
28 more codes
| 99386 | <1% | 70 | $6K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 85 | $5K |
| 93000 | <1% | 308 | $4K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 220 | $3K |
| 93886 | <1% | 28 | $3K | |
| 93892 | <1% | 28 | $3K | |
| 93890 | <1% | 28 | $2K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 12 | $1K |
| 93978 | <1% | 12 | $1K | |
| 99385 | <1% | 26 | $1K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 36 | $400.00 |
| 36415 | Collection of venous blood by venipuncture | <1% | 532 | $363.57 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 25 | $192.50 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 17 | $130.37 |
| 84481 | <1% | 18 | $112.66 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 17 | $85.44 |
| 80050 | General health panel | <1% | 18 | $81.97 |
| 83550 | <1% | 18 | $81.34 | |
| 82728 | <1% | 18 | $76.96 | |
| 83540 | <1% | 18 | $75.89 | |
| 82607 | <1% | 18 | $73.69 | |
| 82746 | <1% | 18 | $72.78 | |
| 84436 | <1% | 17 | $66.42 | |
| 99000 | <1% | 1,210 | $36.75 | |
| 80061 | Lipid panel | <1% | 18 | $32.13 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18 | $23.31 |
| 84480 | <1% | 21 | $15.63 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19 | $6.22 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.